Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve 1. To consider & approve the Audited financial results of the Company for the Quarter/Year ended 31st March, 2025. 2. To take on record the Audit Report of the Statutory Auditors for the Audited Financial Results of the Company for the Quarter/Year ended 31st March, 2025. 3. To consider and approve the Audited Financial Statements, including the Balance Sheet, as at 31st March, 2025 and the Statement of Profits and Loss and Cash flow, statement of change in equity and notes thereon for the year ended 31st March, 2025. 4. To Appoint Vishakha Agrawal & Associates, Practicing Company Secretaries, as the Secretarial Auditor of the Company for FY 2024-25. 5. Any other business with permission of the Chairman.

pdf

Welcure Drugs & Pharmaceuticals Ltd.

15 May 2025

8.83

-4.95%

AGM

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

BSE India

Intimation of Notice of Postal Ballot for E-Voting

pdf

Welcure Drugs & Pharmaceuticals Ltd.

14 May 2025

8.83

-4.95%

Company Update

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment of Managing Director

pdf

Welcure Drugs & Pharmaceuticals Ltd.

14 May 2025

8.83

-4.95%

Company Update

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & …

BSE India

Amendments to Memorandum of Association

pdf

Welcure Drugs & Pharmaceuticals Ltd.

14 May 2025

8.83

-4.95%

Board Meeting

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting …

BSE India

Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited

pdf

Welcure Drugs & Pharmaceuticals Ltd.

09 May 2025

8.83

-4.95%

Board Meeting

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Intimation for Intimation Of Meeting Of …

BSE India

Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve To consider the appointment of Mr. Chintan Didawala Ganpat (DIN: 11088268) as Managing Director of the Company. 2. To consider the Alteration in Main Objects Clause of Memorandum of Association of the Company by addition of New Objects. 3. To consider the Increase in the Authorized Share Capital of the Company and consequent amendment in Memorandum of the Company, if any; 4. Conduct Postal Ballot by means of E-voting for obtaining approval of the members of the Company

pdf